1
|
Makhoul M, Dewispelaere R, Relvas LJ, Elmaleh V, Caspers L, Bruyns C, Willermain F. Characterization of retinal expression of vascular cell adhesion molecule (VCAM-1) during experimental autoimmune uveitis. Exp Eye Res 2012; 101:27-35. [PMID: 22749846 DOI: 10.1016/j.exer.2012.05.012] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2012] [Revised: 05/15/2012] [Accepted: 05/16/2012] [Indexed: 01/02/2023]
Abstract
Leukocyte adhesion to the blood retinal barrier is a critical step in the pathogenesis of non-infectious uveitis and is mediated in part through the induction of adhesion molecules on retinal cells. Here, we have investigated the retinal expression of Vascular Cell Adhesion Molecule 1 (VCAM-1) in mouse experimental models of non-infectious uveitis. For each eyes, a histological score was given, and the expression of VCAM-1 analyzed by immunohistology. Co-labellings for GFAP, endoglin, aquaporin 4 and recoverin were also performed in order to determine which cell type expressed VCAM-1. In low grade uveitis, obtained after adoptive transfer of semi-purified autoreactive lymphocytes, VCAM-1 was only punctually expressed in the internal limiting membrane and epithelial cells of the ciliary body. Using the same adoptive transfer protocol, we found that, in correlation with disease severity, the staining extended to all internal limiting membranes, vasculitis lesions, Müller cell extensions, outer limiting membranes and RPE cells. VCAM-1 expression in the inner limiting membrane and Müller cell extensions co-stained with GFAP expression. In vasculitis lesions, VCAM-1 co-localized with either GFAP and endoglin expression. The labeling in the outer limiting membrane, did not exactly co-stained with AQ4 (Müller cells marker) or recoverin (photoreceptor marker) and the nature of this expression remained unexplained. Finally, VCAM-1 expression was also analyzed in classical experimental autoimmune uveitis eyes, and a similar pattern of expression was found. In conclusion VCAM-1 is expressed on all blood retinal barrier cells during experimental non-infectious uveitis and might thus play an important role in inflammatory cell recruitment during disease development.
Collapse
Affiliation(s)
- M Makhoul
- I.R.I.B.H.M (Institute of Interdisciplinary Research), Université Libre de Bruxelles Campus Erasme, Brussels, Belgium.
| | | | | | | | | | | | | |
Collapse
|
2
|
Koch P, Degreef S, Chtarto A, Kisma N, Bruyns C, Caspers L, Tenenbaum L, Willermain F. 015 Optimisation du transfert de gènes au niveau des cellules ARPE in vitro dans le cadre de modèles de rejet immun. J Fr Ophtalmol 2007. [DOI: 10.1016/s0181-5512(07)79827-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
3
|
Driessens G, Harsan L, Robaye B, Waroquier D, Browaeys P, Giannakopoulos X, Velu T, Bruyns C. Micronuclei to detect in vivo chemotherapy damage in a p53 mutated solid tumour. Br J Cancer 2003; 89:727-9. [PMID: 12915886 PMCID: PMC2376913 DOI: 10.1038/sj.bjc.6601163] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
Apoptosis induction and micronuclei formation were compared following cytotoxic treatments in two rat glioma differing in p53 integrity. In vitro, micronuclei emergence but not apoptosis was linked to the p53 mutated status. In vivo, micronuclei assays were more sensitive to evaluate DNA damage induced by chemotherapy in a p53-mutated solid tumour.
Collapse
Affiliation(s)
- G Driessens
- Interdisciplinary Research Institute (IRIBHM), Faculty of Medicine, Université Libre de Bruxelles, 1070 Brussels, Belgium
| | - L Harsan
- Faculty of Physics, Babes-Bolyai University, 3400 Cluj-Napoca, Rumania
| | - B Robaye
- Interdisciplinary Research Institute (IRIBHM), Faculty of Medicine, Université Libre de Bruxelles, 1070 Brussels, Belgium
| | - D Waroquier
- Interdisciplinary Research Institute (IRIBHM), Faculty of Medicine, Université Libre de Bruxelles, 1070 Brussels, Belgium
| | - P Browaeys
- Interdisciplinary Research Institute (IRIBHM), Faculty of Medicine, Université Libre de Bruxelles, 1070 Brussels, Belgium
| | - X Giannakopoulos
- Interdisciplinary Research Institute (IRIBHM), Faculty of Medicine, Université Libre de Bruxelles, 1070 Brussels, Belgium
| | - T Velu
- Interdisciplinary Research Institute (IRIBHM), Faculty of Medicine, Université Libre de Bruxelles, 1070 Brussels, Belgium
- Department of Medical Oncology, Erasme Hospital, 1070 Brussels, Belgium
| | - C Bruyns
- Interdisciplinary Research Institute (IRIBHM), Faculty of Medicine, Université Libre de Bruxelles, 1070 Brussels, Belgium
- Interdisciplinary Research Institute (IRIBHM), Faculty of Medicine, Université Libre de Bruxelles, 1070 Brussels, Belgium. E-mail:
| |
Collapse
|
4
|
Velu T, Brandenburger A, Bruyns C, Gangji D, Tenenbaum L. [The medical oncology clinic]. Rev Med Brux 2003; 23 Suppl 2:131-6. [PMID: 12584929] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/28/2023]
Abstract
The clinic of medical oncology is mainly devoted to the development of new anticancer treatments based on molecular biology and immunology. The clinic was the first in Belgium to start a protocol of gene therapy. Scientific contributions deal with the role of various oncogens in cell transformation, the interaction between cancer and the immune system and, new tools for the molecular diagnosis of cancers. Focus was particularly put on the development of new vectors for gene therapy and antitumor cell vaccines for cell therapy.
Collapse
|
5
|
Cabay L, Willermain F, Bruyns C, Verdebout JM, Witta Y, Baffi J, Velu T, Libert J, Caspers-Velu L, Maho A, Lespagnard L. CXCR4 expression in vitreoretinal membranes. Br J Ophthalmol 2003; 87:567-9. [PMID: 12714394 PMCID: PMC1771640 DOI: 10.1136/bjo.87.5.567] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BACKGROUND/AIM Proliferative vitreoretinopathy (PVR) and macular pucker (MP) vitreoretinal membranes are caused by abnormal cell migration. By their role in chemotactism, chemokine receptors represent good candidates to sustain this process. The authors thus investigated the expression of one of them, CXCR4, in these pathologies. METHODS Three PVR and four MP membranes were surgically removed and processed for immunochemical studies with antibodies for CXCR4, cytokeratins or smooth muscle actin. RESULTS CXCR4 expression was found in all membranes. There was no relation between severity of PVR or MP and presence of CXCR4. In addition, there was no difference in CXCR4 expression between MP and PVR. CONCLUSION CXCR4 is expressed in PVR and MP. Further experiments are needed to test if CXCR4 and other chemokine receptors are implicated in vitreoretinal membrane formation.
Collapse
Affiliation(s)
- L Cabay
- Department of Ophthalmology, CHU, Saint-Pierre, Brussels, Belgium IRIBHM, Université Libre de Bruxelles, Brussels, Belgium
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Willermain F, Caspers-Velu L, Nowak B, Stordeur P, Mosselmans R, Salmon I, Velu T, Bruyns C. Retinal pigment epithelial cells phagocytosis of T lymphocytes: possible implication in the immune privilege of the eye. Br J Ophthalmol 2002; 86:1417-21. [PMID: 12446378 PMCID: PMC1771383 DOI: 10.1136/bjo.86.12.1417] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
AIM To investigate the capability of retinal pigment epithelium (RPE) cells to phagocytose T lymphocytes and to further analyse the immunobiological consequences of this phagocytosis. METHODS Human RPE cells pretreated or not by cytochalasin, a phagocytosis inhibitor, were co-cultured with T lymphocytes for different time points. Phagocytosis was investigated by optic microscopy, electron microscopy, and flow cytometry. T cell proliferation was measured by (3)H thymidine incorporation. RPE interleukin 1beta mRNA expression was quantified by real time PCR. RESULTS RPE cells phagocytose apoptotic and non-apoptotic T lymphocytes, in a time dependent manner. This is an active process mediated through actin polymerisation, blocked by cytochalasin E treatment. Inhibition of RPE cell phagocytosis capabilities within RPE-T cell co-cultures led to an increase of lectin induced T cell proliferation and an upregulation of interleukin 1beta mRNA expression in RPE cells. CONCLUSIONS It is postulated that T lymphocyte phagocytosis by RPE cells might, by decreasing the total number of T lymphocytes, removing apoptotic lymphocytes, and downregulating the expression of IL-1beta, participate in vivo in the induction and maintenance of the immune privilege of the eye, preventing the development of intraocular inflammation.
Collapse
Affiliation(s)
- F Willermain
- Interdisciplinary Research Institute (IRIBHN), Université Libre de Bruxelles, Belgium.
| | | | | | | | | | | | | | | |
Collapse
|
7
|
Bercovici N, Massicard S, Agrawal S, Pauillac F, Duffour M, Boccaccio C, Boyer A, Nardin A, Chauvet I, Prigent D, Fabbro MO, Goxe B, Latour N, Heshmati F, Duriau D, Lehmann F, Bruyns C, Velu T, Romet-Lemonne JL, Abastado JP, Salcedo M. Dendritic cells generated in the presence of IL-13 and GM-CSF in a GMP large scale production process are potent tumor antigen stimulators and are well tolerated by cancer patients. Eur J Cancer 2001. [DOI: 10.1016/s0959-8049(01)80395-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
8
|
Bruyns C, Montgomery K, Wildermuth S. A virtual environment for simulated rat dissection. Stud Health Technol Inform 2001; 81:75-81. [PMID: 11317821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
Animal dissection for the scientific examination of organ subsystems is a delicate procedure. Performing this procedure under the complex environment of microgravity presents additional challenges because of the limited training opportunities available that can recreate the altered gravity environment. Traditional crew training often occurs several months in advance of experimentation, provides limited realism, and involves complicated logistics. We have developed an interactive virtual environment that can simulate several common tasks performed during animal dissection. In this paper, we describe the imaging modality used to reconstruct the rat in virtual space, provide an overview of the simulation environment and briefly discuss some of the techniques used to manipulate the virtual rat.
Collapse
Affiliation(s)
- C Bruyns
- Lockheed Martin Space Operations, Mail Stop 239-11, Moffett Field, CA 94035, USA
| | | | | |
Collapse
|
9
|
Wilkin F, Duhant X, Bruyns C, Suarez-Huerta N, Boeynaems JM, Robaye B. The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J Immunol 2001; 166:7172-7. [PMID: 11390464 DOI: 10.4049/jimmunol.166.12.7172] [Citation(s) in RCA: 152] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Recently, it has been shown that ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells (DC); the effect of ATP was reproduced by hydrolysis-resistant derivatives of ATP and was blocked by suramin, suggesting the involvement of a P2 receptor, but the particular subtype involved was not identified. In this report we confirm that ATP and various derivatives synergize with TNF-alpha and LPS to induce the maturation of human monocyte-derived DC, as revealed by up-regulation of the CD83 marker and the secretion of IL-12. The rank order of potency of various analogs (AR-C67085 > adenosine 5'-O-(3-thiotriphosphate) = 2'- and 3'-O-(4-benzoyl-benzoyl) ATP > ATP > 2-methylthio-ATP) was close to that of the recombinant human P2Y11 receptor. Furthermore, these compounds activated cAMP production in DC, in a xanthine-insensitive way, consistent with the involvement of the P2Y11 receptor, which among P2Y subtypes has the unique feature of being dually coupled to phospholipase C and adenylyl cyclase activation. The involvement of the P2Y11/cAMP/protein kinase A signaling pathway in the nucleotide-induced maturation of DC is supported by the inhibitory effect of H89, a protein kinase A inhibitor. Taken together, our results demonstrate that ATP activates DC through stimulation of the P2Y11 receptor and subsequent increase in intracellular cAMP.
Collapse
Affiliation(s)
- F Wilkin
- Institute of Interdisciplinary Research, Institut de Biologie et de Médecine Moléculaires, Université Libre de Bruxelles, Gosselies, Belgium.
| | | | | | | | | | | |
Collapse
|
10
|
Toungouz M, Libin M, Bulté F, Faid L, Lehmann F, Duriau D, Laporte M, Gangji D, Bruyns C, Lambermont M, Goldman M, Velu T. Transient expansion of peptide-specific lymphocytes producing IFN-gamma after vaccination with dendritic cells pulsed with MAGE peptides in patients with mage-A1/A3-positive tumors. J Leukoc Biol 2001; 69:937-43. [PMID: 11404379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/20/2023] Open
Abstract
Assessment of T-cell activation is pivotal for evaluation of cancer immunotherapy. We initiated a clinical trial in patients with MAGE-A1 and/or -A3 tumors using autologous DC pulsed with MAGE peptides aimed at analyzing T-cell-derived, IFN-gamma secretion by cytokine flow cytometry and ELISPOT. We also tested whether further KLH addition could influence this response favorably. Monocyte-derived DC were generated from leukapheresis products. They were pulsed with the relevant MAGE peptide(s) alone in group A (n=10 pts) and additionally with KLH in group B (n=16 pts). A specific but transient increase in the number of peripheral blood T lymphocytes secreting IFN-gamma in response to the vaccine peptide(s) was observed in 6/8 patients of group A and in 6/16 patients of group B. We conclude that anti-tumor vaccination using DC pulsed with MAGE peptides induces a potent but transient anti-MAGE, IFN-gamma secretion that is not influenced by the additional delivery of a nonspecific, T-cell help.
Collapse
Affiliation(s)
- M Toungouz
- Unité de Thérapie Cellulaire et Moléculaire (U.T.C.M.), Erasme Hospital and Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Toungouz M, Libin M, Bulté F, Faid L, Lehmann F, Duriau D, Laporte M, Gangji D, Bruyns C, Lambermont M, Goldman M, Velu T. Transient expansion of peptide‐specific lymphocytes producing IFN‐γ after vaccination with dendritic cells pulsed with MAGE peptides in patients with mage‐A1/A3‐positive tumors. J Leukoc Biol 2001. [DOI: 10.1189/jlb.69.6.937] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Affiliation(s)
- M. Toungouz
- Unité de Thérapie Cellulaire et Moléculaire (U.T.C.M.), Université Libre de Bruxelles, Brussels, Belgium
| | - M. Libin
- Unité de Thérapie Cellulaire et Moléculaire (U.T.C.M.), Université Libre de Bruxelles, Brussels, Belgium
| | - F. Bulté
- Unité de Thérapie Cellulaire et Moléculaire (U.T.C.M.), Université Libre de Bruxelles, Brussels, Belgium
| | - L. Faid
- Department of Medical Oncology, Université Libre de Bruxelles, Brussels, Belgium
| | - F. Lehmann
- Department of Medical Oncology, Université Libre de Bruxelles, Brussels, Belgium
| | - D. Duriau
- Department of Medical Oncology, Université Libre de Bruxelles, Brussels, Belgium
| | - M. Laporte
- Department of Dermatology, Université Libre de Bruxelles, Brussels, Belgium
| | - D. Gangji
- Department of Medical Oncology, Université Libre de Bruxelles, Brussels, Belgium
| | - C. Bruyns
- Interdisciplinary Research Institute (IRIBHN), and Université Libre de Bruxelles, Brussels, Belgium
| | - M. Lambermont
- Unité de Thérapie Cellulaire et Moléculaire (U.T.C.M.), Université Libre de Bruxelles, Brussels, Belgium
| | - M. Goldman
- Department of Immuno‐Hematology‐Tranfusion, Erasme Hospital and Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium
| | - T. Velu
- Department of Medical Oncology, Université Libre de Bruxelles, Brussels, Belgium
- Interdisciplinary Research Institute (IRIBHN), and Université Libre de Bruxelles, Brussels, Belgium
| |
Collapse
|
12
|
Willermain F, Caspers-Velu L, Baudson N, Dubois C, Hamdane M, Willems F, Velu T, Bruyns C. Role and expression of CD40 on human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2000; 41:3485-91. [PMID: 11006243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2023] Open
Abstract
PURPOSE To examine the CD40 costimulatory molecule expression on normal resting or activated adult human retinal pigment epithelium (hRPE) cells and to evaluate its role as an activation molecule considering the potential antigen presentation functions of hRPE cells. METHODS Expression of HLA-DR and costimulatory (CD40, B7.1, B7.2, CD54, and CD58) molecules on hRPE cells was analyzed by flow cytometry. CD40 triggering was performed using soluble CD40L or cocultures with CD40L transfected fibroblasts. Interleukin (IL)-6, -8, -10, and -12 secretions were measured by enzyme-linked immunosorbent assay. Antigen presentation function of hRPE cells was assessed by coculturing hRPE cells with allogeneic T cells. T-cell proliferation was measured by [(3)H]-thymidine incorporation, and T-cell apoptosis by measurement of caspase-3 activity. RESULTS Interferon (IFN)gamma-activated hRPE cells expressed CD40, but not B7.1 or B7.2. Although interferongamma enhanced IL-6 and IL-8 production, CD40 triggering of IFNgamma-activated hRPE cells did not induce IL-12 secretion. hRPE cells did not stimulate allogeneic resting T cells and downregulated phytohemagglutinin-activated allogeneic T cells via a cell-to-cell contact-dependent mechanism. Some induction of apoptosis was detected. CONCLUSIONS CD40 is expressed on IFNgamma-activated hRPE cells. Its ligation leads to an increased production of IL-6 and IL-8 but fails to induce B7.1 or B7. 2 expression, or to induce IL-12 secretion. Accordingly, hRPE cells do not activate allogenic T cells but inhibit T-cell proliferation, partly through induction of apoptosis. These results suggest that hRPE cells could be implicated more in a deviant antigen presentation. If the exact molecular mechanisms are unclear, it is likely that CD40-CD40L interaction could play a role in this process.
Collapse
Affiliation(s)
- F Willermain
- I.R.I.B.H.N., Campus Erasme, Université Libre de Bruxelles, Faculty of Medicine, Brussels, Belgium.
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Ross MD, Twombly IA, Bruyns C, Cheng R, Senger S. Telecommunications for health care over distance: the Virtual Collaborative Clinic. Stud Health Technol Inform 2000; 70:286-91. [PMID: 10977558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
Affiliation(s)
- M D Ross
- University of New Mexico Health Sciences Center, Albuquerque 87131-5042, USA
| | | | | | | | | |
Collapse
|
14
|
Bruyns C, Pesesse X, Moreau C, Blero D, Erneux C. The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2 are coexpressed in human T lymphocytes. Biol Chem 1999; 380:969-74. [PMID: 10494849 DOI: 10.1515/bc.1999.120] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
The activation of many hematopoietic cells via cytokine receptors, as well as B and T cell receptors, leads to the tyrosine phosphorylation of Shc and its association with both Grb2-Sos1 complexes and with a 145 kDa protein referred to as the SH2 containing inositol 5-phosphatase (SHIP1). In a search of putative 5-phosphatase isoenzymes, we have isolated a second SH2 domain containing inositol 5-phosphatase, referred to as (SHIP2). Both SHIP1 and SHIP2 are coexpressed in human T lymphocytes. This was shown at the protein level by Western blot analysis in transformed T cell lines and in peripheral blood T lymphocytes either unstimulated or after in vitro activation through TCR-CD3 complex. SHIP1 protein level was not modulated after activation of T lymphocytes, in contrast to SHIP2, which was increased after long-term stimulation. SHIP1 was tyrosine phosphorylated in resting naive T cells. This was not observed in the transformed T cell lines. T lymphocyte is therefore a model of coexpression of the two SH2-containing inositol 5-phosphatases SHIP1 and SHIP2.
Collapse
Affiliation(s)
- C Bruyns
- Interdisciplinary Research Institute (IRIBHN), Université Libre de Bruxelles, Brussels, Belgium
| | | | | | | | | |
Collapse
|
15
|
Leclercq V, Hamdane M, Bruyns C, Faid L, Gangji D, Velu T. Immunothérapie génique du cancer : bilan et perspectives. Med Sci (Paris) 1999. [DOI: 10.4267/10608/1402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
16
|
Bartholeyns J, Romet-Lemonne JL, Chokri M, Buyse M, Velu T, Bruyns C, Van de Winkel JJ, Heeney J, Koopman G, Malmsten M, De Groote D, Monsigny M, Midoux P, Alarcon B. Cellular vaccines. Res Immunol 1998; 149:647-9. [PMID: 9851517 DOI: 10.1016/s0923-2494(99)80032-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
This project is devoted to the development of novel cellular vaccines designed to treat cancer patients. These cellular vaccines present and enhance immunogens, which will elicit a potent immune response. The goal is to achieve safe and effective immune reaction against the patient's own tumour. (1) Autologous cellular vaccines are prepared by processing circulating blood mononuclear cells outside of the patient's body (ex vivo) to differentiate them into antigen-presenting cells (APCs). Monocyte-derived APCs (MD-APCs) are then grown in the presence of exogenous target antigens (tumour cell debris, or apoptotic bodies) to become fully mature APCs. (2) Functionality for antigen presentation to T cells of ex vivo MD-APCs is evaluated in vivo. (3) Cellular vaccines are tested in selected rodent animal models. Efficiency and immune response are monitored in pertinent experimental systems for cancer. Pharmacological data are generated for clinical investigation. Tolerance and biologic effects are documented in primates. (4) The first clinical trials on cancer patients are taking place in 1998 on melanoma and prostate cancer to validate the concept. Specialized cell processors with dedicated software and standardized controls are being developed and used for the preparation of cellular vaccines. (5) The evaluation of new non-viral vectors and the validation of new non-viral transfection methods of mononuclear cells with marker genes is in progress and will lead to the ex vivo transfection of genes coding for immunostimulating cytokines or for tumour antigens in MD-APCs. Efficiency will be validated in vitro and in animal models. The ex vivo and animal model studies validate the clinical relevance of this new cellular immunotechnology. Clinical validation of individual autologous cellular vaccines in specific indications for which no treatment is presently available will allow the development of cellular and gene immunotherapy for other types of cancers.
Collapse
|
17
|
Marchant A, Amraoui Z, Gueydan C, Bruyns C, Le Moine O, Vandenabeele P, Fiers W, Buurman WA, Goldman M. Methylprednisolone differentially regulates IL-10 and tumour necrosis factor (TNF) production during murine endotoxaemia. Clin Exp Immunol 1996; 106:91-6. [PMID: 8870704 PMCID: PMC2200560 DOI: 10.1046/j.1365-2249.1996.d01-799.x] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
IL-10 is an endogenous antiinflammatory cytokine that inhibits TNF biosynthesis and protects mice from lipopolysaccharide (LPS)-induced lethality. As synthetic glucocorticoids are widely used as antiinflammatory agents, we analysed the effects of methylprednisolone administration on IL-10 biosynthesis during murine endotoxaemia. We found that low doses of methylprednisolone (2-10 mg/kg) markedly inhibited TNF production but did not affect serum levels of IL-10, while a high methylprednisolone dose (50 mg/kg) increased LPS-induced IL-10 levels. In parallel, we observed that LPS-induced IL-10 production is TNF-independent in this experimental setting. Experiments conducted in vitro indicated that methylprednisolone (from 0.01 to 100 micrograms/ml) also increased the biosynthesis of IL-10 by LPS-activated mouse peritoneal macrophages. We conclude that methylprednisolone differentially regulates IL-10 and TNF production induced by LPS both in vivo and in vitro at the macrophage level.
Collapse
Affiliation(s)
- A Marchant
- Laboratoire d'immunologie Expérimentale, Université Libre de Bruxelles, Belgium
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Gérard CM, Bruyns C, Delvaux A, Baudson N, Dargent JL, Goldman M, Velu T. Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells. Hum Gene Ther 1996; 7:23-31. [PMID: 8825865 DOI: 10.1089/hum.1996.7.1-23] [Citation(s) in RCA: 62] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
Because interleukin-10 (IL-10) has potent immunosuppressive and anti-inflammatory properties and is produced by some cancers, we hypothesized that its production might play a role in carcinogenesis by inhibiting adequate antitumoral immune responses. To test this hypothesis, retroviral vectors containing the IL-10 cDNA were generated and used to infect B16F1 melanoma cells that were injected subcutaneously in syngeneic mice. Surprisingly, IL-10 gene transfer resulted in a loss of tumorigenicity that was proportional to the amount of IL-10 secreted. Histological analysis showed massive area of necrosis of these tumor cells, with infiltration of polymorphic inflammatory cells. Parental cells simultaneously implanted had decreased tumorigenicity only when mixed with IL10-producing cells, but not when injected contralaterally, suggesting that their eradication is mediated mostly by a local phenomenon. Host T lymphocytes and natural killer (NK) cells were involved in this eradication because IL-10-producing cells grew in nude mice and in CD8+ or NK-depleted mice. Finally, mice injected with IL-10-secreting cells developed an antitumoral systemic immune response able to protect them against a subsequent challenge with parental cells. These results demonstrate that, in some settings, IL10 may have in vivo immunostimulating and proinflammatory properties that need to be considered in its therapeutic development.
Collapse
Affiliation(s)
- C M Gérard
- Institut de Recherche Interdisciplinaire, Brussels, Belgium
| | | | | | | | | | | | | |
Collapse
|
19
|
Donckier V, Wissing M, Bruyns C, Abramowicz D, Lybin M, Vanderhaeghen ML, Goldman M. Critical role of interleukin 4 in the induction of neonatal transplantation tolerance. Transplantation 1995; 59:1571-6. [PMID: 7778172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Neonatal injection of semiallogeneic cells is known to promote differentiation of donor-specific CD4+ T cells into TH2-like cells in the peripheral lymphoid organs. We reasoned that the propensity of neonatal T cells to synthesize high levels of IL-4 might be involved in this polarization of the alloreactive response and thereby in the development of neonatal transplantation tolerance. First, analysis of cytokine gene expression in lymph nodes after neonatal injection of 10(7) (A/J x BALB/c)F1 cells in BALB/c mice indicated that IL-4 but not IL-2 is rapidly produced by CD4+ cells after allogeneic challenge in vivo. To determine whether the early production of IL-4 was involved in the establishment of allotolerance, BALB/c mice neonatally injected with (A/J x BALB/c)F1 spleen cells received on days 1 and 3 after birth 1 mg of anti-IL-4 mAb (11B11) or the same amount of control mAb. When grafted with A/J skin at 4 weeks, 88% of mice treated with control mAb retained their graft for more than 50 days, whereas rejection occurred within 30 days in 93% of mice treated with anti-IL-4 mAb. Analysis of T cell functions after in vitro restimulation with A/J spleen cells indicated that early IL-4 neutralization did not prevent donor-specific CTL unresponsiveness but allowed the emergence of alloreactive T cells secreting increased levels of IL-2 and IFN-gamma. We conclude that early production of IL-4 is critical for the establishment of neonatal transplantation tolerance in this strain combination, which has disparities across the entire H-2 region.
Collapse
Affiliation(s)
- V Donckier
- Laboratoire Pluridisciplinaire de Recherche Expérimentale Biomédicale-Department of Immunology, Hôpital Erasme, Université Libre de Bruxelles, Belgium
| | | | | | | | | | | | | |
Collapse
|
20
|
Donckier V, Wissing M, Abramowicz D, Bruyns C, Vanderhaeghen ML, Lybin M, Goldman M. Early neutralization of IL-4 but not of IL-10 abrogates neonatal induction of transplantation tolerance in mice. Transplant Proc 1995; 27:186-7. [PMID: 7878967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Affiliation(s)
- V Donckier
- Hopital Erasme, Université Libre de Bruxelles, Belgium
| | | | | | | | | | | | | |
Collapse
|
21
|
Gérard C, Bruyns C, Goldman M, Velu T. Interleukine-10: facteur favorisant l'échappement d'une tumeur à la surveillance immunitaire ? ou facteur favorisant son rejet ? Med Sci (Paris) 1995. [DOI: 10.4267/10608/2324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
22
|
Delvaux A, Donckier V, Bruyns C, Florquin S, Gérard C, Amraoui Z, Abramowicz D, Goldman M, Velu T. Effects of systemic administration of rIL-10 in an in vivo model of alloreactivity. Transplantation 1994; 58:972-4. [PMID: 7940750 DOI: 10.1097/00007890-199410270-00025] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Affiliation(s)
- A Delvaux
- Department of Medical Genetics, Institut de Recherche Interdisciplinaire en Biologie Humaine et Nucléaire, Université Libre de Bruxelles, Belgium
| | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Donckier V, Abramowicz D, Bruyns C, Florquin S, Vanderhaeghen ML, Amraoui Z, Dubois C, Vandenabeele P, Goldman M. IFN-gamma prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice. The Journal of Immunology 1994. [DOI: 10.4049/jimmunol.153.6.2361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Abstract
BALB/c mice injected at birth with 10(8) (A/J X BALB/c)F1 hybrid spleen cells develop an autoimmune host-vs-graft (HVG) disease as a result of activation of donor B cells by host CD4+ cells. The antidonor CD4+ cells seem to be Th2-like cells, inasmuch as they are profoundly deficient in IL-2 and IFN-gamma production, but secrete high levels of IL-4 and IL-10. As IFN-gamma is known to inhibit the development of TH2 cells, we attempted to modulate HVG disease by injecting rIFN-gamma. First, we found that 10 micrograms of rIFN-gamma given on days 1 and 3 after birth reduced the serum hyper-IgE of HVG mice by 90% and the serum hyper-IgG1, by 70%. In addition, rIFN-gamma administration significantly decreased the anti-DNA IgG1 titers and prevented the occurrence of anti-glomerular basement membrane and anti-laminin IgG1 Abs as well as the formation of immune deposits in renal glomeruli. These effects were not caused by the abrogation of chimerism, as indicated by the persistence of donor-type B cells in lymph nodes and of Igs bearing donor allotype in serum. MLC experiments indicated that the major effect of early rIFN-gamma administration was to restore the production of IL-2 and IFN-gamma by donor-specific T cells while these cells still secreted significant amounts of IL-4 and IL-10. Unresponsiveness of antidonor cytolytic T cells was not influenced by rIFN-gamma. We conclude that rIFN-gamma prevents the TH2-type response induced by the neonatal injection of semiallogeneic spleen cells and the associated pathology.
Collapse
Affiliation(s)
- V Donckier
- Interdisciplinary Laboratory of Experimental Biomedical Research Free University of Brussels, Belgium
| | - D Abramowicz
- Interdisciplinary Laboratory of Experimental Biomedical Research Free University of Brussels, Belgium
| | - C Bruyns
- Interdisciplinary Laboratory of Experimental Biomedical Research Free University of Brussels, Belgium
| | - S Florquin
- Interdisciplinary Laboratory of Experimental Biomedical Research Free University of Brussels, Belgium
| | - M L Vanderhaeghen
- Interdisciplinary Laboratory of Experimental Biomedical Research Free University of Brussels, Belgium
| | - Z Amraoui
- Interdisciplinary Laboratory of Experimental Biomedical Research Free University of Brussels, Belgium
| | - C Dubois
- Interdisciplinary Laboratory of Experimental Biomedical Research Free University of Brussels, Belgium
| | - P Vandenabeele
- Interdisciplinary Laboratory of Experimental Biomedical Research Free University of Brussels, Belgium
| | - M Goldman
- Interdisciplinary Laboratory of Experimental Biomedical Research Free University of Brussels, Belgium
| |
Collapse
|
24
|
Donckier V, Abramowicz D, Bruyns C, Florquin S, Vanderhaeghen ML, Amraoui Z, Dubois C, Vandenabeele P, Goldman M. IFN-gamma prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice. J Immunol 1994; 153:2361-8. [PMID: 8077653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
BALB/c mice injected at birth with 10(8) (A/J X BALB/c)F1 hybrid spleen cells develop an autoimmune host-vs-graft (HVG) disease as a result of activation of donor B cells by host CD4+ cells. The antidonor CD4+ cells seem to be Th2-like cells, inasmuch as they are profoundly deficient in IL-2 and IFN-gamma production, but secrete high levels of IL-4 and IL-10. As IFN-gamma is known to inhibit the development of TH2 cells, we attempted to modulate HVG disease by injecting rIFN-gamma. First, we found that 10 micrograms of rIFN-gamma given on days 1 and 3 after birth reduced the serum hyper-IgE of HVG mice by 90% and the serum hyper-IgG1, by 70%. In addition, rIFN-gamma administration significantly decreased the anti-DNA IgG1 titers and prevented the occurrence of anti-glomerular basement membrane and anti-laminin IgG1 Abs as well as the formation of immune deposits in renal glomeruli. These effects were not caused by the abrogation of chimerism, as indicated by the persistence of donor-type B cells in lymph nodes and of Igs bearing donor allotype in serum. MLC experiments indicated that the major effect of early rIFN-gamma administration was to restore the production of IL-2 and IFN-gamma by donor-specific T cells while these cells still secreted significant amounts of IL-4 and IL-10. Unresponsiveness of antidonor cytolytic T cells was not influenced by rIFN-gamma. We conclude that rIFN-gamma prevents the TH2-type response induced by the neonatal injection of semiallogeneic spleen cells and the associated pathology.
Collapse
Affiliation(s)
- V Donckier
- Interdisciplinary Laboratory of Experimental Biomedical Research Free University of Brussels, Belgium
| | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gérard C, Delvaux A, De Groote D, Abramowicz D, Velu T, Goldman M. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 1994; 24:1167-71. [PMID: 8181527 DOI: 10.1002/eji.1830240524] [Citation(s) in RCA: 223] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Interleukin-10 (IL-10) is a potent inhibitor of lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF) production and has been shown to protect mice from endotoxin shock. As IFN-gamma is another important mediator of LPS toxicity, we studied the effects of IL-10 on LPS-induced IFN-gamma synthesis in vitro and in vivo. First, we found that the addition of recombinant human IL-10 (rhIL-10) (10 U/ml) to human whole blood markedly suppressed LPS-induced IFN-gamma release while neutralization of endogenously synthesized IL-10 resulted in increased IFN-gamma levels. The ability of rIL-10 to inhibit LPS-induced IFN-gamma synthesis was also observed in vivo in mice. Indeed, administration of 1000 U recombinant mouse IL-10 (rmIL-10) 30 min before and 3 h after challenge of BALB/c mice with 100 micrograms LPS resulted in a threefold decrease in peak IFN-gamma serum levels. We then examined the production and the role of IL-10 during murine endotoxemia. We found that LPS injection causes the rapid release of IL-10, peak IL-10 serum levels being observed 90 min after LPS challenge. Neutralization of endogenously produced IL-10 by administration of 2 mg JES5-2A5 anti-IL-10 monoclonal antibody (mAb) 2 h before LPS challenge resulted in a marked increase in both TNF and IFN-gamma serum levels while irrelevant isotype-matched mAb had no effect. The enhanced production of inflammatory cytokines in anti-IL-10 mAb-treated mice was associated with a 60% lethality after injection of 500 micrograms LPS, while all mice pretreated with control mAb survived. We conclude that the rapid release of IL-10 during endotoxemia is a natural antiinflammatory response controlling cytokine production and LPS toxicity.
Collapse
Affiliation(s)
- A Marchant
- Hôpital Erasme-Department of Immunology, Brussels, Belgium
| | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Affiliation(s)
- C Bruyns
- Hôpital Erasme, Department of Medical Genetics, Université Libre de Bruxelles, Belgium
| | | | | |
Collapse
|
27
|
Gérard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993; 177:547-50. [PMID: 8426124 PMCID: PMC2190913 DOI: 10.1084/jem.177.2.547] [Citation(s) in RCA: 578] [Impact Index Per Article: 18.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
Because of its ability to efficiently inhibit in vitro cytokine production by activated macrophages, we hypothesized that interleukin (IL) 10 might be of particular interest in preventing endotoxin-induced toxicity. We therefore examined the effects of IL-10 administration before lipopolysaccharide (LPS) challenge in mice. A marked reduction in the amounts of LPS-induced tumor necrosis factor (TNF) release in the circulation was observed after IL-10 pretreatment at doses at low as 10 U. IL-10 also efficiently prevented the hypothermia generated by the injection of 100 micrograms LPS. Finally, pretreatment with a single injection of 1,000 U IL-10 completely prevented the mortality consecutive to the challenge with 500 micrograms LPS, a dose that was lethal in 50% of the control mice. We conclude that IL-10 inhibits in vivo TNF secretion and protects against the lethality of endotoxin in a murine model of septic shock.
Collapse
Affiliation(s)
- C Gérard
- Institut de Recherche Interdisciplinaire, Université Libre de Bruxelles, Belgium
| | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Abramowicz D, Vandervorst P, Bruyns C, Doutrelepont JM, Vandenabeele P, Goldman M. Persistence of anti-donor allohelper T cells after neonatal induction of allotolerance in mice. Eur J Immunol 1990; 20:1647-53. [PMID: 2145162 DOI: 10.1002/eji.1830200805] [Citation(s) in RCA: 32] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
BALB/c mice rendered tolerant to A/J alloantigens by neonatal injection of 10(8) (A/J X BALB/c)F1 spleen cells develop an autoimmune disease associated with a polyclonal activation of donor B cells. To study the mechanisms leading to donor B cell activation in tolerant mice, we prepared mixed lymphocyte cultures (MLC) between splenic T cells from neonatally injected mice and donor-type (A/J X BALB/c)F1 or third-party (C57BL/6 X BALB/c)F1 B cells. T cells from tolerized mice were unable to generate cytotoxic T lymphocytes, to proliferate or to secrete interleukin (IL)2 after stimulation with donor alloantigens in MLC. These T cell responses were present after MLC with third-party antigens, but were of lower intensity than those generated by control BALB/c T cells. In contrast, T cells from tolerized mice stimulated immunoglobulin production by donor-type (A/J X BALB/c)F1 B cells much more powerfully than T cells from control BALB/c mice. The stimulation of donor-type (A/J X BALB/c)F1 B cells was polyclonal, as attested by the levels of anti-hapten and anti-DNA antibodies in the MLC supernatants. IgM was the dominant isotype secreted in vitro, but IgG1 and IgG3 were also produced in significant amounts. Lysis experiments indicated that the T cells responsible for F1 B cell stimulation in MLC were CD4+ host T cells. These T helper cells were alloreactive since they did not stimulate syngeneic BALB/c B cells, and their effect on donor B cells was specifically blocked by anti-donor Ia monoclonal antibodies. Addition of anti-IL 4 monoclonal antibody to MLC between T cells from tolerant mice and (A/J X BALB/c)F1 B cells almost completely abolished the production of IgG1, but not that of IgM or IgG3. Taken together, these findings indicate that neonatal injection of alloantigens in BALB/c mice induces a state of dissociated tolerance, with unresponsiveness of anti-donor T cells secreting IL 2 on the one hand, and persistence of T cells responsible for B cell help and IL 4 secretion on the other hand.
Collapse
Affiliation(s)
- D Abramowicz
- Laboratoire Pluridisciplinaire de Recherche Expérimentale, Biomédicale et Service de Néphrologie, Cliniques Universitaires de Bruxelles, Hôpital Erasme, Brussels, Belgium
| | | | | | | | | | | |
Collapse
|
29
|
Bruyns C, Jeener R. Relationship between the synthesis of autoimmune antibodies and the formation of clusters of B, T and APC cells during the syngeneic mixed lymphocyte reaction in BALB/c and NZB mice: a technique for isolation of the spleen autoimmune compartment of non-immunized pathogen-free mice. Res Immunol 1990; 141:491-504. [PMID: 2149464 DOI: 10.1016/0923-2494(90)90018-t] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Cells from the spleens of non-immunized mice were cultured in horizontal tubes, rotating very slowly around their long axis. Under these conditions, the flux speed gradient of the cell suspension near the tube walls greatly increased the chances of cells coming into contact with one another. Mixed clusters of B, T and APC cells were soon found adhering firmly to the walls of the tube; cluster formation leveled off after about 3 h. The clustered cells were easily separated from those remaining in suspension and constituted a particular cell compartment comprising a maximum of 20-30% of the total. B cells from this compartment, cultured in complete medium for 48 h, almost exclusively produced IgM antibodies. Antibodies reacting with self antigens were so numerous in the culture medium that it is likely all IgM were self antibodies. That the clusters obtained under these conditions constituted a compartment of autoimmune cells is supported by previous work which showed that 20-30% of spleen cells secrete IgM antibodies almost exclusively. Cluster formation as a function of age was compared in NZB mice which are used as a model of lupus erythematosus, and in BALB/c mice which never manifest self-immune pathology. The number of cells found in clusters per whole spleen increased exponentially with age in NZB mice and linearly in BALB/c mice. The production of autoimmune antibodies as a function of age also increased exponentially for NZB mice and linearly in BALB/c mice, which provides further striking support for the hypothesis that the clusters formed constitute the autoimmune comportment.
Collapse
Affiliation(s)
- C Bruyns
- Laboratoire de Physiologie Animale, Université Libre de Bruxelles, Rhode-St-Genèse, Belgium
| | | |
Collapse
|
30
|
Abramowicz D, Doutrelepont JM, Lambert P, Van der Vorst P, Bruyns C, Goldman M. Increased expression of Ia antigens on B cells after neonatal induction of lymphoid chimerism in mice: role of interleukin 4. Eur J Immunol 1990; 20:469-76. [PMID: 2138556 DOI: 10.1002/eji.1830200303] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
BALB/c mice rendered chimeric at birth by injection of 10(8) (A/J X BALB/c)F1 spleen cells develop a lupus-like autoimmune disease linked to the activation of donor B cells by host T cells. As in vitro studies previously indicated that interleukin 4 (IL4) was a mediator of the interactions between T and B cells, we analyzed the intensity of Ia antigen expression on B cells of chimeric mice. Flow cytometric analysis with anti-Ia monoclonal antibodies (mAb) revealed that B cells from spleens and lymph nodes of 2-week-old chimeric BALB/c mice displayed a two- to threefold increase in membrane Ia antigen expression, this increase still being present in spleens of 30-week-old animals. An increase in Ia antigen expression was also found in the small number of donor B cells detected in spleens and lymph nodes of chimeric mice. IL4 was the major stimulus leading to increased B cell Ia antigen expression, as this phenomenon was substantially prevented by in vivo treatment of chimeric mice with the anti-IL4 11B11 mAb. In vitro experiments revealed that host splenic T cells of chimeric mice, while unable to generate anti-donor cytotoxic T lymphocytes, secreted significant amounts of IL 4 when stimulated in mixed lymphocyte cultures (MLC) with donor alloantigens. This IL4 secretion led to an increased expression of Ia antigens on donor-type F1 B cells present in MLC. No significant increase in Ia antigen expression was found on syngeneic BALB/c B cells co-cultured with T cells from chimeric mice unless A/J B cells were added to the cultures. Taken together, these findings indicate that increased Ia antigen expression on donor B cells is induced by IL4 secreted by anti-donor T cells. IL4 released in this setting also leads to increased Ia antigen expression on host B cells through a bystander effect.
Collapse
Affiliation(s)
- D Abramowicz
- Laboratoire Pluridisciplinaire de Recherche Expérimentale Biomédicale, Cliniques Universitaires de Bruxelles, Belgium
| | | | | | | | | | | |
Collapse
|
31
|
Goldman M, Vandervorst P, Lambert P, Doutrelepont JM, Bruyns C, Abramowicz D. Persistence of anti-donor helper T cells secreting interleukin 4 after neonatal induction of transplantation tolerance. Transplant Proc 1989; 21:238-9. [PMID: 2523130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- M Goldman
- Laboratoire Pluridisciplinaire de Recherche Expérimentale Biomédicale, Université Libre de Bruxelles, Belgium
| | | | | | | | | | | |
Collapse
|
32
|
Sneyers M, Thiriart C, Bruyns C, Lambert AF, Collignon C, Schwers A, Coppe P, Antoine H, Franssen JD, Urbain J. Detection of rotavirus in faecal specimens with a monoclonal antibody enzyme-linked immunosorbent assay: comparison with polyclonal antibody enzyme immuno-assays and a latex agglutination test. Comp Immunol Microbiol Infect Dis 1989; 12:95-104. [PMID: 2558838 PMCID: PMC7134035 DOI: 10.1016/0147-9571(89)90058-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Monoclonal antibodies have been produced against the 81/36F strain of rotavirus. One of them, was chosen as diagnostic reagent: it showed high ELISA reactivity with all the bovine, human and porcine rotavirus strains tested and reacted with VP6, structural protein product known to support the common rotavirus antigen. A sandwich ELISA procedure using the chosen monoclonal as "capture and detecting" antibody was performed to detect rotavirus in faecal samples from experimentally inoculated newborn calves: it always gave a negative response with meconium and a positive response for the stool specimens which rotavirus have been isolated. This assay was compared with Enzygnost and Slidex Rota Kit tests and with a non-commercial sandwich ELISA test using polyclonal antibodies: it showed more sensitivity than the agglutination test and was as sensitive as the other two tests to detect rotavirus in routine diagnostic material. The test evaluated showed no equivocal results.
Collapse
Affiliation(s)
- M Sneyers
- Faculté de Médecine vétérinaire de l'Université de Liège, Institut de Chimie, Belgium
| | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Goldman M, Abramowicz D, Lambert P, Vandervorst P, Bruyns C, Toussaint C. Hyperactivity of donor B cells after neonatal induction of lymphoid chimerism in mice. Clin Exp Immunol 1988; 72:79-83. [PMID: 3260841 PMCID: PMC1541507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
Balb/c mice made chimaeric by neonatal injection of semi-allogeneic (A/J x Balb/c)F1 hybrid spleen cells develop anti-DNA and rheumatoid factor-like antibodies in the context of hypergammaglobulinaemia with marked elevation of IgG1 and IgE serum levels. Chimaeric mice also display increased levels of antibodies to different haptens and to tobacco mosaic virus (TMV). The allotypic marker of the A/J strain is present on anti-DNA and anti-hapten antibodies. In addition, spleen cells of chimaeric mice spontaneously produce high levels of IgG1 and anti-DNA antibodies in vitro and this hyperactivity is abolished after lysis of donor lymphocytes. These findings indicate that polyclonal activation of donor B cells plays an important role in this model of autoimmunity.
Collapse
Affiliation(s)
- M Goldman
- Laboratoire Pluridisciplinaire de Recherche Expérimentale Biomédicale, Universitaires de Bruxelles, Hôpital Erasme, Belgium
| | | | | | | | | | | |
Collapse
|
34
|
Abramowicz D, Van der Vorst P, Bruyns C, Lambert P, Goldman M. Autoimmunity and glomerulonephritis after neonatal induction of lymphoid chimerism in mice: role of donor B cells and host T cells. Nephrol Dial Transplant 1988; 3:399-404. [PMID: 3140124 DOI: 10.1093/oxfordjournals.ndt.a091687] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
Balb/c mice neonatally injected with semiallogeneic (A/J x Balb/c) F1 or (C57 BL/6 x Balb/c) F1 hybrid spleen cells develop autoantibodies, marked increase in serum levels of IgG1 and IgE, lymphoid hyperplasia, and immune-complex glomerulonephritis. F1 donor B cells play a dominant role in the pathogenesis of this autoimmune disease since B-cell chimerism is required for the occurrence of immunopathology, donor-specific allotype is expressed on serum anti-DNA antibodies, and substantial amounts of donor-derived immunoglobulins are present in the kidney eluate of chimeric mice. In vitro experiments indicate that T cells from diseased Balb/c mice induce activation of F1 donor B cells with secretion of anti-DNA antibodies. These findings suggest that a host-versus-graft reaction between recipient T cells and donor F1 B cells is responsible for the secretion of pathogenic antibodies in this model.
Collapse
Affiliation(s)
- D Abramowicz
- Laboratoire Pluridisciplinaire de Recherche Expérimentale Biomédicale, Cliniques Universitaires de Bruxelles, Hôpital Erasme, Belgium
| | | | | | | | | |
Collapse
|
35
|
Abramowicz D, Bruyns C, Goldman M. Chimerism and cytotoxic T lymphocyte unresponsiveness after neonatal injection of spleen cells in mice. Effects of T cell depletion and of a semiallogeneic or fully allogeneic inoculum. Transplantation 1987; 44:696-701. [PMID: 3500534 DOI: 10.1097/00007890-198711000-00019] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Newborn Balb/c mice received a single neonatal injection of either (A/J x Balb/c) F1 hybrid spleen cells, T-cell-depleted (A/J x Balb/c) F1 hybrid spleen cells, or T-cell-depleted fully allogeneic A/J spleen cells. Chimerism was followed longitudinally during the life span by the detection of circulating donor allotype. At sacrifice, the percentage of donor cells in the spleen was measured, and cytotoxic T lymphocyte (CTL) reactivity to the tolerogen was tested. We found that T cell depletion of the semiallogeneic inoculum did not modify its capacity to generate persistent chimerism and CTL tolerance, while T-cell-depleted allogeneic cells were intrinsically deficient both in the induction and in the long-term maintenance of chimerism and CTL unresponsiveness.
Collapse
Affiliation(s)
- D Abramowicz
- Laboratoire de Physiologie Animale, Hôpital Erasme, Université Libre de Bruxelles, Belgium
| | | | | |
Collapse
|
36
|
Abramowicz D, Goldman M, Bruyns C, Lambert P, Thoua Y, Toussaint C. Autoimmune disease after neonatal injection of semi-allogeneic spleen cells in mice: involvement of donor B and T cells and characterization of glomerular deposits. Clin Exp Immunol 1987; 70:61-7. [PMID: 3319303 PMCID: PMC1542205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Abstract
Balb/c neonates injected with semi-allogeneic (A/J x Balb/c) F1 hybrid spleen cells develop an autoimmune disease associated with an immune-complex glomerulonephritis. The successful induction and maintenance of B cell chimerism is required for the occurrence of autoimmunity. The percentage of chimeric mice displaying autoimmune features increases in parallel with the number of cells injected at birth. T cell depleted inocula although readily inducing B cell chimerism were found unable to induce hypergammaglobulinaemia, circulating immune complexes and glomerulonephritis. IgG1 is the most and IgG3 the least represented IgG isotype among the immunoglobulins deposited in the glomeruli. Immunoglobulins bearing donor (A/J) allotype are detected in the glomeruli of six out of 11 chimeric mice. Rheumatoid factor activity is significantly concentrated within the immunoglobulins eluted from the kidneys, whereas anti-DNA activity is not.
Collapse
Affiliation(s)
- D Abramowicz
- Laboratoire Pluridisciplinaire de Recherche Expérimentale Biomédicale, Cliniques Universitaires de Bruxelles, Hôpital Erasme, Brussels, Belgium
| | | | | | | | | | | |
Collapse
|
37
|
Goldman M, Abramowicz D, Bruyns C. [Allogenic interactions in immunopathology]. Presse Med 1985; 14:1921-5. [PMID: 2933695] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Abstract
Allogeneic interactions associated with experimental graft-versus-host reaction are sometimes responsible for the development of autoantibodies, immune complex lesions and malignant lymphocytic proliferation. Hypergammaglobulinaemia reflects the activation of B cells, and T cell-associated responses are deeply depressed. Some of these abnormalities are also found in chimera mice following injection of semi-allogeneic cells. The place of allogeneic interactions in human pathology has not yet been determined, but they might intervene in the pathogenesis of some autoimmune and lymphoproliferative diseases and in the acquired immune deficiency syndrome.
Collapse
|
38
|
Urbain J, Brait M, Bruyns C, Demeur C, Dubois P, Francotte M, Franssen JD, Hiernaux J, Leo O, Marvel J. The idiotypic network: order from the beginning or order out of chaos? Curr Top Microbiol Immunol 1985; 119:127-42. [PMID: 3910361 DOI: 10.1007/978-3-642-70675-2_9] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
39
|
Demeur C, Urbain-Vansanten G, Vaeck M, Bruyns C, Urbain J. A study of in vitro primary responses from rabbit peripheral blood lymphocytes. Immunol Lett 1981. [DOI: 10.1016/0165-2478(81)90023-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
40
|
Bazin H, Beckers A, Urbain-Vansanten G, Pauwels R, Bruyns C, Tilkin AF, Platteau B, Urbain J. Transplantable IgD immunoglobulin-secreting tumors in rat. J Immunol 1978; 121:2077-82. [PMID: 712079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
The LOU/C/Wsl rat inbred strain presents a high incidence of spontaneous malignant ileocecal immunocytomas or monoclonal immunoglobulin-secreting tumors. Some tumors have been transplanted in histocompatible animals over years without any change in their secretion products. Among approximately 600 different monoclonal proteins we have studied so far, we recognized six showing properties different from those of rat IgM, IgA, IgE, or IgG classes, and characteristic of the IgD class.
Collapse
|
41
|
Bazin H, Beckers A, Urbain-Vansanten G, Pauwels R, Bruyns C, Tilkin AF, Platteau B, Urbain J. Transplantable IgD Immunoglobulin-Secreting Tumors in Rat. The Journal of Immunology 1978. [DOI: 10.4049/jimmunol.121.5.2077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Abstract
The LOU/C/Wsl rat inbred strain presents a high incidence of spontaneous malignant ileocecal immunocytomas or monoclonal immunoglobulin-secreting tumors. Some tumors have been transplanted in histocompatible animals over years without any change in their secretion products. Among approximately 600 different monoclonal proteins we have studied so far, we recognized six showing properties different from those of rat IgM, IgA, IgE, or IgG classes, and characteristic of the IgD class.
Collapse
Affiliation(s)
- H. Bazin
- Experimental Immunology Unit, University of Louvain, Clos Chapelle-aux-Champs, 30 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Laboratory of Animal Physiology, Université Libre de Bruxelles, 67, rue des Chevaux From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Department of Chest Diseases, Academic Hospital, De Pintelaan, 135 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
| | - A. Beckers
- Experimental Immunology Unit, University of Louvain, Clos Chapelle-aux-Champs, 30 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Laboratory of Animal Physiology, Université Libre de Bruxelles, 67, rue des Chevaux From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Department of Chest Diseases, Academic Hospital, De Pintelaan, 135 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
| | - G. Urbain-Vansanten
- Experimental Immunology Unit, University of Louvain, Clos Chapelle-aux-Champs, 30 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Laboratory of Animal Physiology, Université Libre de Bruxelles, 67, rue des Chevaux From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Department of Chest Diseases, Academic Hospital, De Pintelaan, 135 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
| | - R. Pauwels
- Experimental Immunology Unit, University of Louvain, Clos Chapelle-aux-Champs, 30 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Laboratory of Animal Physiology, Université Libre de Bruxelles, 67, rue des Chevaux From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Department of Chest Diseases, Academic Hospital, De Pintelaan, 135 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
| | - C. Bruyns
- Experimental Immunology Unit, University of Louvain, Clos Chapelle-aux-Champs, 30 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Laboratory of Animal Physiology, Université Libre de Bruxelles, 67, rue des Chevaux From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Department of Chest Diseases, Academic Hospital, De Pintelaan, 135 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
| | - A. F. Tilkin
- Experimental Immunology Unit, University of Louvain, Clos Chapelle-aux-Champs, 30 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Laboratory of Animal Physiology, Université Libre de Bruxelles, 67, rue des Chevaux From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Department of Chest Diseases, Academic Hospital, De Pintelaan, 135 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
| | - B. Platteau
- Experimental Immunology Unit, University of Louvain, Clos Chapelle-aux-Champs, 30 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Laboratory of Animal Physiology, Université Libre de Bruxelles, 67, rue des Chevaux From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Department of Chest Diseases, Academic Hospital, De Pintelaan, 135 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
| | - J. Urbain
- Experimental Immunology Unit, University of Louvain, Clos Chapelle-aux-Champs, 30 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Laboratory of Animal Physiology, Université Libre de Bruxelles, 67, rue des Chevaux From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
- Department of Chest Diseases, Academic Hospital, De Pintelaan, 135 From the , 1200 Brussels, Belgium , and The , 1640 Rhode-St-Genèse, Belgium , and The , 9000 Gent, Belgium
| |
Collapse
|
42
|
Tasiaux N, Leuwenkroon R, Bruyns C, Urbain J. Possible occurrence and meaning of lymphocytes bearing autoanti-idiotypic receptors during the immune response. Eur J Immunol 1978; 8:464-8. [PMID: 308455 DOI: 10.1002/eji.1830080704] [Citation(s) in RCA: 43] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
During an immune response, the increase in binding affinity of antibodies is followed by a fall. Lymphocytes bearing autoanti-idiotypic receptors were detected during a normal immune response. The kinetics of appearance and disappearance of such lymphocytes led us to propose a network model to explain the changes occurring in antibody properties during an immune response.
Collapse
|
43
|
Bruyns C, Urbain-Vansanten G, Planard C, Vos-Cloetens C, Urbain J. Ontogeny of mouse B lymphocytes and inactivation by antigen of early B lymphocytes. Proc Natl Acad Sci U S A 1976; 73:2462-6. [PMID: 1084996 PMCID: PMC430609 DOI: 10.1073/pnas.73.7.2462] [Citation(s) in RCA: 33] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Taking advantage of recent findings about membrane fluidity, we have studied and compared the biosynthetic capacities of fetal or neonatal mouse B (bone-marrow derived) lymphocytes (until 10 days after birth) and adult B lymphocytes. Although both early and adult lymphocytes can synthesize surface immunoglobulins, they have a different physiological behavior after interaction with a ligand (anti-immunoglobulin sera or antigen), either in vivo or in vitro. Fetal and neonatal lymphocytes bearing surface immunoglobulins do not reexpress their membrane receptors after capping and endocytosis promoted by anti-immunoglobulin sera. On the other hand, adult lymphocytes resynthesize completely their receptors after the same treatment. Furthermore, intrafetal injections of hemocyanin in pregnant mice lead to a striking decrease in the number of hemocyanin-binding cells. It seems plausible that this non-reexpression of surface immunoglobulins could be the first step in tolerance establishment.
Collapse
|
44
|
Urbain-Vansanten G, Richard C, Bruyns C, Hooghe V, Van Acker A, Urbain J. High number of antigen-binding cells in unimmunized mice and possible occurrence of multispecific lymphocytes. Ann Immunol (Paris) 1974; 125:885-900. [PMID: 4619318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|